Saturday, July 5, 2025 7/5/2025

Cerebral hemodynamic impairment in symptomatic and asymptomatic Alzheimer's Disease

Award Number: R01AG072603
ORGANIZATION: NATIONAL INSTITUTE ON AGING
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 02/01/2022
PERIOD OF PERFORMANCE END DATE: 01/31/2027

Group Awards By:

View Award Description

Cerebral hemodynamic impairment in symptomatic and asymptomatic Alzheimer's Disease - Abstract Alzheimer's Disease (AD) is rapidly becoming an overwhelming economic and social burden. It is estimated that 13.8 million Americans will have AD in 2050 and the total annual payments for health, long-term, and hospice care for AD and other dementias will increase to $1.2 trillion in 2050. Despite the important role of cerebrovascular function in AD, studies on cerebrovascular impairment in the asymptomatic phase of AD are lacking. The proposed project directly addresses this important scientific area by using advanced MR imaging techniques to study biomarkers of cerebrovascular function in AD subjects both before and after the manifestation of clinical symptoms. The overarching goal of the proposed project is to study whether AD pathology directly interacts with cerebrovascular pathology in the early phases of the AD continuum, as well as the relative contributions of cerebrovascular and AD pathologies to cognitive impairments in early AD. (1) We will use an advanced MR technique for measuring cerebrovascular reactivity (CVR) as a biomarker of vascular function and study CVR in 264 subjects composed of four groups including healthy young and middle-aged subjects (HY), cognitive normal elderly without AD pathology (CN-), asymptomatic AD subjects who are cognitively normal with positive AD pathology (aAD), and prodromal AD patients who are symptomatic with mild cognitive impairment and have positive AD pathology (pAD). Longitudinal changes in CVR over two years in CN-, aAD, and pAD subjects will also be studied. (2) We will also study differences in the white matter hyperintensity volume and advanced diffusion metrics between the CN-, aAD, and pAD groups, their longitudinal changes and relationship with CVR. (3) The relative contributions of AD and vascular pathologies to cognitive performance will also be evaluated. The successful execution of the study will provide a better understanding of the interactions between AD pathology and cerebrovascular dysfunction in the early phases of AD continuum that could eventually lead to the development of effective multi-component therapeutic interventions of AD that target both AD and vascular pathologies.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $573,360 )
2025	2025	EMORY UNIVERSITY	201 DOWMAN DR NE	ATLANTA	GA	30322	DEKALB	USA	Aging Research	000	4	3/6/2025	NON-COMPETING CONTINUATION	$526,554
2025	2025	EMORY UNIVERSITY	201 DOWMAN DR NE	ATLANTA	GA	30322	DEKALB	USA	Aging Research	001	4	6/17/2025	NON-COMPETING CONTINUATION	$46,806
														Subtotal = $573,360

Issue Date FY: 2024 ( Subtotal = $927,952 )
2024	2024	EMORY UNIVERSITY	201 DOWMAN DR NE	ATLANTA	GA	30322	DEKALB	USA	Aging Research	001	3	6/25/2024	NON-COMPETING CONTINUATION	$92,796
2024	2024	EMORY UNIVERSITY	201 DOWMAN DR	ATLANTA	GA	30322	DEKALB	USA	Aging Research	000	3	1/23/2024	NON-COMPETING CONTINUATION	$835,156
														Subtotal = $927,952

Issue Date FY: 2023 ( Subtotal = $862,222 )
2023	2023	EMORY UNIVERSITY	201 DOWMAN DR	ATLANTA	GA	30322	DEKALB	USA	Aging Research	000	2	2/3/2023	NON-COMPETING CONTINUATION	$862,222
														Subtotal = $862,222

Issue Date FY: 2022 ( Subtotal = $857,527 )
2022	2022	EMORY UNIVERSITY	201 DOWMAN DR	ATLANTA	GA	30322	DEKALB	USA	Aging Research	000	1	1/19/2022	NEW	$857,527
														Subtotal = $857,527

Grand Total All Awards = $3,221,061

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Cerebral hemodynamic impairment in symptomatic and asymptomatic Alzheimer's Disease

Award Number: R01AG072603

ORGANIZATION: NATIONAL INSTITUTE ON AGING

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 02/01/2022

PERIOD OF PERFORMANCE END DATE: 01/31/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer